Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines-Reference-Cited by-同舟云学术

Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines

Published:2013-08 Issue:35 Volume:31 Page:3623-3627
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Izurieta Hector S.,Zuber Patrick,Bonhoeffer Jan,Chen Robert T.,Sankohg Osman,Laserson Kayla F.,Sturkenboom Miriam,Loucq Christian,Weibel Daniel,Dodd Caitlin,Black Steve

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference39 articles.

1. What is pharmacoepidemiology;Strom,2012

2. Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010;Ouandaogo;Vaccine,2012

3. Capacity for a global vaccine safety system: the perspective of national regulatory authorities;Graham;Vaccine,2012

4. The Global Alliance for Vaccines and Immunization: http://www.one.org/c/us/policybrief/3260.

5. WHO. Draft Global Vaccine Action Plan (GVAP). http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_22-en.pdf.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine pharmacovigilance in South Africa: successes and limitations of current approaches;Expert Opinion on Drug Safety;2024-08-08

2. Landscape review of active vaccine safety surveillance activities for COVID-19 vaccines globally;Vaccine: X;2024-06

3. Collaboration within the global vaccine safety surveillance ecosystem during the COVID-19 pandemic: lessons learnt and key recommendations from the COVAX Vaccine Safety Working Group;BMJ Global Health;2024-03

4. Adverse Events to SARS-CoV-2 (COVID-19) Vaccines and Policy Considerations that Inform the Funding of Safety Surveillance in Low- and Middle-Income Countries: A Mixed Methods Study;Drug Safety;2023-02-22

5. Adverse Event Following Immunization (AEFI) in Children: An Analysis of Reporting in VigiAccess;Drug Research;2022-06-20